VIVUS Inc. Message Board
-
STENDRA DEADLINE APRIL, 27, 2013
Anybody who has followed VVUS knows a deal must happen by this date including the analysts and institutional investors who want your shares.Why do you think VVUS just sighned a lease for a 45,000 sq. ft. building with a SPRING posession?
Sentiment: Strong Buy
-
QQQQQQQQQQQ
Sentiment: Strong Buy
-
YUP YUP
Sentiment: Strong Buy
-
QQQQQQQQQQQ
Sentiment: Strong Buy
-
qqqqq
Sentiment: Strong Buy
-
QQQQQQ
Sentiment: Strong Buy
-
1+1=2. But in Vivus's case it equals $6.5B by April 27.
-
bumper
Sentiment: Strong Buy
- 1 Reply to clear_the_mess_away
-
Less than 3 months away now.
-
This is why Vivus management doesn't sugar coat their quarterly conferences. They know they're selling the whole company Q and Stendra to a BP who has already shown interest. They're not stupid. They know REMS will be amended and Q will be in every large walk in pharmacy across the nation. They know national advertising in every form of media starts in July. They know Stendra will have EU approval in the first quarter of '13. And they know Q receives approval in the EU the first half of '13. The mm's don't have much time left to manipulate this stock.
- 1 Reply to iseedumbpeeple
-
There is no excuse for having a product sit on a shelf for 1 yr doing nothing. There has to be a reason. . Can anyone get information on how Zepeed is selling? If that has flopped for JW pharma perhaps we should all valuate VVUS on Qsymia alone and give zero future potential to STENDRA because that appears to be the scenatio. If it (STENDRA)has value then someones head should roll.
-
It's probably more likely that this is the date on which the tute/hf investors force the BOD into selling the company in pieces for pennies on the dollar. At least those guys don't have their heads in their rectums like most of you guys circle jerkin here.
-
sounds logical to me
Sentiment: Strong Buy
- View More Messages
-